Neuroleptic malignant syndrome-like state in an epileptic patient with organic brain comorbidity treated with zonisamide and carbamazepine.
Azuma
Hideki
H
Negi
Atsushi
A
Hattori
Manabu
M
Masayasu
Tsuji
T
Akechi
Tatsuto
T
Furukawa
Toshi A
TA
D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D001927:Brain Diseases / Q000453:epidemiology*; D002220:Carbamazepine / Q000009:adverse effects* / Q000627:therapeutic use; D015897:Comorbidity; D004827:Epilepsy / Q000188:drug therapy* / Q000453:epidemiology*; D006801:Humans; D007555:Isoxazoles / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000453:epidemiology / Q000209:etiology*; D000078305:Zonisamide
D000927:Anticonvulsants; D007555:Isoxazoles; D002220:Carbamazepine; D000078305:Zonisamide